9 employees
Serina Therapeutics employs its proprietary polymer technology to develop treatments for cancer, inflammation, pain and metabolic disorders.
2007
Serina Therapeutics, Inc. raised undisclosed on August 30, 2022
Investors: Innovate Alabama